Merges leading-edge, rapid-turnaround technology, a team of 8 PhD-level professionals, and continuous technical support to assist biotech and research facilities in achieving their most ambitious goals.
LeoLab™, established in 2018, has set up a manufacturing center in the EU. The center focuses on the production of recombinant proteins and gene synthesis, catering to academia, pharmaceutical R&D, diagnostics, and cell and gene therapy needs for the global market from Europe.
























































